In the case of obese individuals, an elevated BMI has been linked to increased interactional displacement, primarily stemming from the continuous movement of the skin and subcutaneous adiposity [31]
A 2016 review by Sikiric and colleagues in Current Neuropharmacology framed BPC-157's effects within a brain-gut axis model, while a 2024 review by Sikiric and colleagues in Pharmaceuticals (Basel) examined the peptide's relationships with multiple neurotransmitter systems
However, bariatric surgery has been proven to help overweight individuals lose weight, become healthier, and keep the weight off for the long-term
Retatrutide is an investigational triple-receptor agonist, also developed by Eli Lilly
Appetite suppression from the GLP-1 and GIP components appears well-maintained with microdosing, particularly at twice-weekly frequency